Chargement en cours...
Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non‐Small Cell Lung Cancer and the Role of Biopsy at Progression
Molecular profiling and the discovery of drugs that target specific activating mutations have allowed the personalization of treatment for non‐small cell lung cancer (NSCLC). The epithelial growth factor receptor (EGFR) is frequently over‐expressed and/or aberrantly activated in different cancers, i...
Enregistré dans:
| Publié dans: | Oncologist |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley-Blackwell
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5313265/ https://ncbi.nlm.nih.gov/pubmed/27821794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0285 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|